Junjie Ao
Chiba, 2608670, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Targeting Neuropilin-1 for Cancer Pain Treatment: A Trial With Potential for Clinical Translation.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: June 16, 2026
Neuropilin-1 serves as a prognostic marker and a potential target of M2-polarized tumor-associated macrophages in gastric cancer.
Journal: Immunobiology
Published: April 06, 2026
Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11/CCR3 axis in lenvatinib-treated hepatocellular carcinoma.
Journal: Cellular signalling
Published: August 26, 2025
MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma.
Journal: Biochemical pharmacology
Published: October 25, 2024
Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis.
Journal: American journal of physiology. Cell physiology
Published: September 09, 2024
Re-analysis of hepatitis B virus integration sites reveals potential new loci associated with oncogenesis in hepatocellular carcinoma.
Journal: World journal of virology
Published: December 28, 2022
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors.
Journal: Anticancer research
Published: December 06, 2022
Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells.
Journal: Biochemical and biophysical research communications
Published: November 17, 2022
Alteration of the tumor microenvironment by pharmacological inhibition of EZH2 in hepatocellular carcinoma.
Journal: International immunopharmacology
Published: November 07, 2022
Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus.
Journal: International journal of molecular sciences
Published: September 13, 2022
The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma Cells.
Journal: International journal of molecular sciences
Published: June 24, 2022
Effect of Atezolizumab plus Bevacizumab in Patients with Hepatocellular Carcinoma Harboring CTNNB1 Mutation in Early Clinical Experience.
Journal: Journal of Cancer
Published: January 28, 2022
Last Updated: 09/26/2026